Mass Spectrometry Detection for the Masses
By LabMedica International staff writers Posted on 17 Jul 2017 |

Image: Research being conducted uses an atmospheric-pressure glow discharge plasma to probe samples for elemental and molecular species, and could lead to user-friendly MS analyses with broad capabilities (Photo courtesy of the Rensselaer Polytechnic Institute).
Researchers are developing a plasma-based technology to enable generalized use of mass spectrometry (MS) with new instruments that can analyze a much broader range of molecular species than current technology allows.
Current MS instruments are bulky, expensive, and typically specialize in one class of chemicals, discouraging widespread use outside of a specialized lab setting. Better technology is needed to make more flexible instruments. Research being conducted at Rensselaer Polytechnic Institute (Troy, NY, USA) uses an atmospheric-pressure glow discharge plasma – a partially ionized gas that can be made stable at room temperature and pressure – to probe samples for elemental and molecular species, and could lead to user-friendly MS analyses with broad capabilities.
“Ideally we want one system that can detect everything, and we want to be able to take that system into the field to test materials on site,” said Prof. Jacob Shelley of Rensselaer Polytechnic, “We’re trying to make a more flexible instrument that will allow us to detect many things simultaneously.”
The hitch is that current instruments can only analyze molecules that are in gas state and ionized, which means that most samples must first be processed. Current MS relies on a variety of time-consuming processing methods that separate and ionize molecules prior to analysis. And depending on the method, samples (e.g. tissues, pharmaceuticals, or foods) may be destroyed during processing.
The biggest challenge to developing a generalized processing method is the chemistry needed to ionize the molecule. Most methods rely on specific chemistries that favor ionization of one class of molecules over another. Prof. Shelley team is developing a method that takes advantage of the unusual properties and chemistries of plasmas, which are rich in free-moving ions and electrons, and therefore highly interactive. Although the most commonly known plasmas are extremely hot (at nearly 10,000 degrees Kelvin, some plasmas rival the sun’s temperature), the team is working with more recently developed glow discharge plasmas that are stable at room temperature and atmospheric pressure.
In his lab, Prof. Shelley demonstrates an experimental instrument so benign it can test samples ionized from a fingertip, and so versatile it can detect molecular species from small amounts of metals to large labile biomolecules like peptides and proteins. In developing the technology, the team has used the instrument to detect counterfeit honey, to quantify harmful toxins in freshwater algal blooms, and to screen the raw materials used in nutritional supplements.
“The plasma is useful as an ionization source because it makes a diverse range of chemistries available,” said Prof. Shelley, “It may make it possible to ionize a broad class of molecules, which could lead to more generalized instruments.”
This research is enabled by the New Polytechnic vision, a transformative emerging paradigm for higher education, which recognizes that even the most talented person working alone cannot adequately address global challenges and opportunities. It helps Rensselaer serve as a crossroads for collaborations to address some of the world’s most pressing technological challenges.
Related Links:
Rensselaer Polytechnic Institute
Current MS instruments are bulky, expensive, and typically specialize in one class of chemicals, discouraging widespread use outside of a specialized lab setting. Better technology is needed to make more flexible instruments. Research being conducted at Rensselaer Polytechnic Institute (Troy, NY, USA) uses an atmospheric-pressure glow discharge plasma – a partially ionized gas that can be made stable at room temperature and pressure – to probe samples for elemental and molecular species, and could lead to user-friendly MS analyses with broad capabilities.
“Ideally we want one system that can detect everything, and we want to be able to take that system into the field to test materials on site,” said Prof. Jacob Shelley of Rensselaer Polytechnic, “We’re trying to make a more flexible instrument that will allow us to detect many things simultaneously.”
The hitch is that current instruments can only analyze molecules that are in gas state and ionized, which means that most samples must first be processed. Current MS relies on a variety of time-consuming processing methods that separate and ionize molecules prior to analysis. And depending on the method, samples (e.g. tissues, pharmaceuticals, or foods) may be destroyed during processing.
The biggest challenge to developing a generalized processing method is the chemistry needed to ionize the molecule. Most methods rely on specific chemistries that favor ionization of one class of molecules over another. Prof. Shelley team is developing a method that takes advantage of the unusual properties and chemistries of plasmas, which are rich in free-moving ions and electrons, and therefore highly interactive. Although the most commonly known plasmas are extremely hot (at nearly 10,000 degrees Kelvin, some plasmas rival the sun’s temperature), the team is working with more recently developed glow discharge plasmas that are stable at room temperature and atmospheric pressure.
In his lab, Prof. Shelley demonstrates an experimental instrument so benign it can test samples ionized from a fingertip, and so versatile it can detect molecular species from small amounts of metals to large labile biomolecules like peptides and proteins. In developing the technology, the team has used the instrument to detect counterfeit honey, to quantify harmful toxins in freshwater algal blooms, and to screen the raw materials used in nutritional supplements.
“The plasma is useful as an ionization source because it makes a diverse range of chemistries available,” said Prof. Shelley, “It may make it possible to ionize a broad class of molecules, which could lead to more generalized instruments.”
This research is enabled by the New Polytechnic vision, a transformative emerging paradigm for higher education, which recognizes that even the most talented person working alone cannot adequately address global challenges and opportunities. It helps Rensselaer serve as a crossroads for collaborations to address some of the world’s most pressing technological challenges.
Related Links:
Rensselaer Polytechnic Institute
Latest Technology News
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
- Optical Biosensor Rapidly Detects Monkeypox Virus at Point of Care
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read moreMolecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more